ANCA ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODIES EXTENDED PROFILE IgG Test
Test Name: ANCA ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODIES EXTENDED PROFILE IgG Test
Components:
- Anti Proteinase 3 (PR3) Antibody
- Anti Lactoferrin Antibody
- Anti Myeloperoxidase (MPO) Antibody
- Anti Elastase Antibody
- Anti Cathepsin G Antibody
- Anti BPI (Bactericidal Permeability Increasing Protein) Antibody
Price: 1630.0 AED
Sample Condition: 2 mL (1 mL min.) serum from 1 SST. Ship refrigerated or frozen.
Report Delivery: Sample Wed / Fri by 11 am; Report Same day
Method: Enzyme Immunoassay (EIA)
Test type: Autoimmune Disorders
Doctor: Rheumatologist
Test Department: IMMUNOPATHOLOGY
Pre Test Information:
Test Details:
The ANCA (anti-neutrophil cytoplasmic antibodies) extended profile IgG test is a blood test used to detect and measure the levels of IgG antibodies against certain proteins found in the cytoplasm of neutrophils (a type of white blood cell). These antibodies are associated with various autoimmune diseases, particularly vasculitis.
Vasculitis is a condition characterized by inflammation of blood vessels, which can lead to damage and dysfunction of various organs. ANCA-associated vasculitis (AAV) is a specific type of vasculitis that is often associated with the presence of ANCA antibodies.
The ANCA extended profile IgG test is used to help diagnose and monitor AAV and other related autoimmune diseases. It can also help differentiate between different types of AAV, such as granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), and eosinophilic granulomatosis with polyangiitis (EGPA).
During the test, a blood sample is taken and sent to a laboratory for analysis. The sample is tested for the presence and levels of IgG antibodies against specific antigens, such as proteinase 3 (PR3) and myeloperoxidase (MPO), which are commonly targeted by ANCA antibodies.
Elevated levels of ANCA IgG antibodies can indicate the presence of AAV or other related autoimmune diseases. However, it is important to note that a positive result does not necessarily confirm a diagnosis, as these antibodies can also be found in other conditions or even in healthy individuals.
The ANCA extended profile IgG test is typically used in combination with other clinical and laboratory findings to help make a diagnosis. It can also be used to monitor disease activity and response to treatment in individuals with AAV.
It is important to consult with a healthcare provider to interpret the results of the ANCA extended profile IgG test and to determine the appropriate course of action based on the individual’s specific clinical presentation and medical history.
Test Name | ANCA ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODIES EXTENDED PROFILE IgG Test |
---|---|
Components | *Anti Proteinase 3 (PR3) Antibody *Anti Lactoferrin Antibody*Anti Myeloperoxidase (MPO) Antibody *Anti Elastase Antibody*Anti Cathepsin G Antibody *Anti BPI (Bactericidal Permeability Increasing Protein)Antibody |
Price | 1630.0 AED |
Sample Condition | 2 mL (1 mL min.) serum from 1 SST. Ship refrigerated or frozen. |
Report Delivery | SampleWed / Fri by 11 am; Report Same day |
Method | Enzyme Immunoassay (EIA) |
Test type | Autoimmune Disorders |
Doctor | Rheumatologist |
Test Department: | IMMUNOPATHOLOGY |
Pre Test Information | |
Test Details |
The ANCA (anti-neutrophil cytoplasmic antibodies) extended profile IgG test is a blood test used to detect and measure the levels of IgG antibodies against certain proteins found in the cytoplasm of neutrophils (a type of white blood cell). These antibodies are associated with various autoimmune diseases, particularly vasculitis. Vasculitis is a condition characterized by inflammation of blood vessels, which can lead to damage and dysfunction of various organs. ANCA-associated vasculitis (AAV) is a specific type of vasculitis that is often associated with the presence of ANCA antibodies. The ANCA extended profile IgG test is used to help diagnose and monitor AAV and other related autoimmune diseases. It can also help differentiate between different types of AAV, such as granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), and eosinophilic granulomatosis with polyangiitis (EGPA). During the test, a blood sample is taken and sent to a laboratory for analysis. The sample is tested for the presence and levels of IgG antibodies against specific antigens, such as proteinase 3 (PR3) and myeloperoxidase (MPO), which are commonly targeted by ANCA antibodies. Elevated levels of ANCA IgG antibodies can indicate the presence of AAV or other related autoimmune diseases. However, it is important to note that a positive result does not necessarily confirm a diagnosis, as these antibodies can also be found in other conditions or even in healthy individuals. The ANCA extended profile IgG test is typically used in combination with other clinical and laboratory findings to help make a diagnosis. It can also be used to monitor disease activity and response to treatment in individuals with AAV. It is important to consult with a healthcare provider to interpret the results of the ANCA extended profile IgG test and to determine the appropriate course of action based on the individual’s specific clinical presentation and medical history. |